Ascent Wealth Partners’s ResMed RMD Stock Holding History

Ascent Wealth Partners’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$3.23M	Sell	14,624 -16	-0.1%	-$3.49K	0.32%	70
2026 Q2	$2.85M	Buy	14,640 +505	+4%	+$105K	0.29%	73
2026 Q1	$3.17M	Buy	14,135 +624	+5%	+$156K	0.37%	69
2025 Q4	$3.25M	Buy	13,511 +213	+2%	+$54.5K	0.37%	64
2025 Q3	$3.64M	Buy	13,298 +163	+1%	+$44.5K	0.42%	59
2025 Q2	$3.39M	Sell	13,135 -151	-1%	-$36K	0.42%	62
2025 Q1	$2.97M	Buy	13,286 +408	+3%	+$95.2K	0.4%	58
2024 Q4	$2.95M	Sell	12,878 -40	-0.3%	-$9.6K	0.4%	56
2024 Q3	$3.15M	Sell	12,918 -68	-0.5%	-$15.2K	0.44%	55
2024 Q2	$2.49M	Buy	12,986 +6,083	+88%	+$1.23M	0.36%	58
2024 Q1	$1.37M	Buy	+6,903	New	+$1.26M	0.2%	95

Other funds holding RMD

Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return

Vest Financial Mclean, Virginia $9.5B AUM 22.78% 1-Year Est. Return

Washington Trust Advisors Wellesley, Massachusetts $1.4B AUM 26.88% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

UniSuper Management Melbourne, Victoria, Australia $20.4B AUM 33.79% 1-Year Est. Return

Confluence Investment Management St. Louis, Missouri $5.97B AUM 5.11% 1-Year Est. Return

Asset Management One Tokyo, Japan $40B AUM 30.45% 1-Year Est. Return

MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return

Ascent Wealth Partners's RMD Position: Q3 2026 in Review

Ascent Wealth Partners reduced its ResMed (RMD) stake by 0.11% in Q3 2026, selling an estimated $3.49K and leaving 14,624 shares worth $3.23M. The position accounts for 0.32% of the portfolio, ranked #70.

Ascent Wealth Partners first reported a position in RMD in Q1 2024 and has held it in 11 quarters since. The position peaked at $3.64M in Q3 2025. 247 funds tracked by Wall St. Rank hold RMD as of Q3 2026.

Ascent Wealth Partners held 14,624 shares of ResMed worth $3.23M as of Q3 2026.
Ascent Wealth Partners sold 16 ResMed shares in Q3 2026, an estimated $3.49K.
ResMed made up 0.32% of Ascent Wealth Partners's portfolio in Q3 2026, its #70 holding.
Ascent Wealth Partners first reported a position in ResMed in Q1 2024 and has held it in 11 quarters since.
Ascent Wealth Partners's ResMed position peaked at $3.64M in Q3 2025.
247 funds tracked by Wall St. Rank held ResMed as of Q3 2026.

Based on Ascent Wealth Partners's 13F filing for Q3 2026, filed 23 Oct 2026.